BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22512678)

  • 1. Ocular damage in patients with psoriasis treated by psoralen UV-A therapy or narrow band UVB therapy: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():32-5. PubMed ID: 22512678
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():11-21. PubMed ID: 22512676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of psoralen-UVB and psoralen-UVA photochemotherapy in the treatment of psoriasis.
    de Berker DA; Sakuntabhai A; Diffey BL; Matthews JN; Farr PM
    J Am Acad Dermatol; 1997 Apr; 36(4):577-81. PubMed ID: 9092744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical 8-methoxypsoralen increases the efficacy of narrowband ultraviolet B in psoriasis.
    Seckin D; Usta I; Yazici Z; Senol A
    Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):237-41. PubMed ID: 19747241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bath psoralen+ultraviolet A photochemotherapy vs. narrow band-ultraviolet B in psoriasis: a comparison of clinical outcome and effect on circulating T-helper and T-suppressor/cytotoxic cells.
    Salem SA; Barakat MA; Morcos CM
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):235-42. PubMed ID: 20831697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phototherapy and photochemotherapy for psoriasis.
    Racz E; Prens EP
    Dermatol Clin; 2015 Jan; 33(1):79-89. PubMed ID: 25412785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of psoriasis to psoralen-UVB photochemotherapy.
    Sakuntabhai A; Diffey BL; Farr PM
    Br J Dermatol; 1993 Mar; 128(3):296-300. PubMed ID: 8471513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term risks of psoralen and UV-A therapy for psoriasis.
    Farber EM; Abel EA; Cox AJ
    Arch Dermatol; 1983 May; 119(5):426-31. PubMed ID: 6342539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
    Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
    Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photochemotherapy and the eye: photoprotective factors.
    Glew WB; McKeever G; Roberts WP; Malinin G; Nigra TP
    Trans Am Ophthalmol Soc; 1980; 78():243-54. PubMed ID: 7257058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photochemotherapy of psoriasis using methoxsalen and sunlight. A controlled study.
    Parrish JA; White AD; Kingsbury T; Zahar M; Fitzpatrick TB
    Arch Dermatol; 1977 Nov; 113(11):1529-32. PubMed ID: 337903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of photochemotherapy on severe pruritus in polycythemia vera.
    Jeanmougin M; Rain JD; Najean Y
    Ann Hematol; 1996 Aug; 73(2):91-3. PubMed ID: 8774618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation.
    Lafond G; Roy PE; Grenier R
    Can J Ophthalmol; 1984 Jun; 19(4):173-5. PubMed ID: 6744101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eye protection in psoralen photochemotherapy.
    Davey JB; Diffey BL; Miller JA
    Br J Dermatol; 1981 Mar; 104(3):295-300. PubMed ID: 7213563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
    Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
    Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal dystrophy. Occurrence after psoriasis therapy with psoralen and long-wave ultraviolet light.
    Cox AJ; Abel EA
    Arch Dermatol; 1979 May; 115(5):567-70. PubMed ID: 443831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC; Jeanmougin M
    Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Could PUVA therapy and solar lights provoke ocular lesions?].
    De Witte E; Coppens A; Missotten L
    Bull Soc Belge Ophtalmol; 1979; 185():111-7. PubMed ID: 540187
    [No Abstract]   [Full Text] [Related]  

  • 20. Response of psoriatic nails to oral photochemotherapy.
    Marx JL; Scher RK
    Arch Dermatol; 1980 Sep; 116(9):1023-24. PubMed ID: 7416754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.